Tag Archives: COVID-19

SARS-CoV-2 is that its effects on individuals differ

One thing that we know about SARS-CoV-2 is that its effects on individuals differ. This coronavirus continues to bring new shocks as the pandemic rolls on.

A team of researchers and physicians has now documented the case of one woman with leukemia who had no signs of COVID-19, but she was already shedding infectious SARS-CoV-2 particles 70 days after her first complimentary examination.

This outcome is much longer than prior reports of hospitalized adults observed shedding contagious SARS-CoV-2 virus up to 20 days after their diagnosis of COVID-19, plus other reports of individuals shedding genetic material from the virus up to 63 days after the first appearance of their symptoms.


Reference
Startling Case Study Finds Asymptomatic COVID-19 Carrier …. https://monkeyviral.com/startling-case-study-finds-asymptomatic-covid-19-carrier-who-shed-virus-for-70-days/

Some Covid-19 patients experience a long-lasting skin issues following the infection

Some Covid-19 patients experience a long-lasting skin issues following the infection, researchers from Massachusetts General Hospital are finding, including rashes, hives, and “Covid toes,” underpinning previous, limited research about a collection of new symptoms connected with Covid-19 and yet another troubling sign that for a few the herpes virus could have an enduring impact.

The research unearthed that some patients reported skin issues for as much as five months, though an average of patients only experiences observable symptoms for 12 days.

This set of Covid-19 symptoms contributes to mounting evidence that, for a few, the illness may be a long haul — lots of people are now calling this the “long Covid.”

Symptoms varied in severity, though generally mild, researchers said, you need to include rashes, hives, and chilblains, the very last of that your researchers have termed “Covid toes.”

The findings that have been presented in the EADV Virtual congress Thursday and result from studying the info of nearly 1,000 long Covid cases in 39 different countries may help scientists comprehend the body’s inflammatory reaction to Covid-19 infection.
Reference
‘Covid Toes,’ Rashes, And Hives: New Research Underpins …. https://www.forbes.com/sites/roberthart/2020/10/29/covid-toes-rashes-and-hives-new-research-underpins-covid-19s-long-term-skin-impact/

The spread of the Covid-19 among members in a family group

The spread of the Covid-19 among members in a family group after one individual is infected is “common” and occurs quickly after illness onset, relating to new research through the US Centers for Disease Control and Prevention.

The person exposed or suspected of experiencing Covid-19 should always be isolated before getting tested, and before test outcomes get back to protect others in the home, said the analysis, published Friday when looking at the CDC’s Morbidity and Mortality Weekly Report.

“Because prompt isolation of persons with #COVID-19 can lessen household transmission, persons who suspect which they could have COVID-19 should isolate, stay in the home, and employ an independent bedroom and bathroom if feasible,” wrote a CDC-led team of researchers.
All people in family members should also wear masks all of the time per space, the group said.

Referencehttps://www.cnn.com/2020/10/30/health/household-spread-covid-19-wellness/index.html
Household spread of Covid-19 is common and quick, a new CDC study finds. https://www.cnn.com/2020/10/30/health/household-spread-covid-19-wellness/index.html.

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment with its trial studying the antibody cocktail treatment, which was fond of President Trump earlier this month. The choice is because of potential safety concerns.
The drugmaker on Friday said it was suspending the enrollment of hospitalized #COVID-19 patients requiring high-flow oxygen or mechanical ventilation after an unbiased monitoring committee observed “a potential safety signal and an unfavorable risk/benefit profile at the moment.”

The enrollment of individuals in this category should be on hold, pending the collection and evaluation of additional data.

Trials continue to test the antibody cocktail in hospitalized patients necessitating little if any extra oxygen. Other trials involving mild or moderately ill patients also can move ahead.

The drug has revealed encouraging outcomes. Regeneron on Wednesday said early data confirmed the therapy lowered COVID-19 related medical visits by 57 percent.

Regeneron earlier this month asked the foodstuff and Drug Administration for emergency approval and said it could make doses accessible to the American people free of charge. The drugmaker said it might have sufficient doses for 300,000 people when looking at the coming months.

Reference

Regeneron stops enrolling critically ill COVID-19 patients …. https://news.immitate.com/2020/10/30/regeneron-stops-enrolling-critically-ill-covid-19-patients-for-antibody-drug-trial-thehill-the-hill/.

Resistance to Covid-19 infection remains for at least five months

Resistance to Covid-19 infection remains for at least five months, investigators reported — and probably lengthier than that.

While the study may seem perplexing and contradictory to a comparable report out of Britain this week, it is not. People’s bodies generate an army of immune substances in response to an infection, and many are complicated at first, succumbing off quickly, while others develop more gradually.

The new account out Wednesday reveals 90% of men and women who recover from #Covid-19 infections maintain a stable antibody reaction.

British study demonstrates proof of subsiding immunity to Covid-19.

Although some researchers have suggested antibodies to this virus go away rapidly, experts have found just the reverse — that more than 90% of individuals who were moderately or averagely ill produce an antibody response strong adequate to counteract the virus, and the response is preserved for countless months.
This is important for successful vaccine improvement.

Can one get infected with Covid-19 two times? It is challenging
The team examined the antibody responses of more than 30,000 people who tested positive for Covid-19 at Mount Sinai’s Health System between March and October. They characterized their antibody reactions as minimal, moderate, or high. At least 90% had moderate to high amounts, or titers, of antibodies to the virus’s surge protein — the structure it uses to grip the cells it infects.

They then accurately studied 121 individuals who restored and contributed their plasma — once three months after they first produced signs, and again five months later.
Reference
Immunity to coronavirus lingers for months, study finds. https://www.cnn.com/2020/10/29/health/covid-immunity-lingers-months-wellness/index.html

Over 80 percent of 200 COVID-19 sufferers in a hospital in Spain have vitamin D deficiency

Over 80 percent of 200 COVID-19 sufferers in a hospital in Spain have vitamin D deficiency, relating to new research published when looking at the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Vitamin D is a hormone the kidneys generate that manages blood calcium amount and impacts the immune protection system. Vitamin D deficiency happens to be connected to many health problems, although scientific studies are still underway into why the hormone impacts other systems regarding the body. Many studies point out the beneficial affectation of vitamin D on the immune protection system, especially about protecting infections.

“One approach is always to identify and treat vitamin D deficiency, particularly in high-risk individuals, for instance, the elderly, patients with comorbidities, and nursing home residents, who will be the key target population for the COVID-19,” said study co-author José L. Hernández, Ph.D., regarding the University of Cantabria in Santander, Spain. “Vitamin D treatment should always be recommended in COVID-19 patients with lower levels of vitamin D circulating when you look at the blood because this approach could have beneficial effects both in the musculoskeletal in addition to the immune protection system.”

The investigators found that 80 percent of 216 COVID-19 patients in the Hospital Universitario Marqués de Valdecilla had vitamin D deficiency, and men had lower vitamin D levels than women. COVID-19 patients with reduce vitamin D levels also had increased serum amounts of inflammatory markers such as ferritin and D-dimer.
Reference
Over 80% of Hospitalized COVID-19 Patients Have Vitamin D Deficiency, Study Finds. https://scitechdaily.com/over-80-of-hospitalized-covid-19-patients-have-vitamin-d-deficiency-study-finds/

A brand new study made headlines this week that features people claiming mouthwash could combat COVID-19

A brand new study made headlines this week that features people claiming mouthwash could comba#t COVID-19.

Mouthwash is a day to day item that’s employed by many people several times just about every day. Also, it could have a large impact if it becomes a possible cure or treatment for the #coronavirus.
The analysis was launched this week by a Penn State College of Medicine research team led by Craig Meyers. They found certain oral antiseptics and mouthwashes could have the capability to inactivate human #coronaviruses.

https://wthr.com/embeds/video/507-6a81e8c9-e83a-4dbe-8d7b-f338b070a1af/iframe?jwsource=cl

Several tables into the study’s text show that one to two minutes of utilizing Johnson & Johnson baby shampoo as a nasal rinse inactives significantly more than 99% for the present virus while at the very least 30 seconds of Crest Pro-Health, Listerine Antiseptic, Listerine Ultra, Equate Antiseptic, CVS Antiseptic Mouthwash, and Betadine 5% bottles of mouthwash inactivate up to or maybe more than 99.99% of virus in your mouth.

As well as the tested mouthwashes that were less efficient still took care of most of the virus. “Most for the common over‐the‐counter mouthwashes/gargles tested demonstrated at the least a 90% decrease in infectious virus at 1 min of contract time using the greater part of products showing increasing virucidal activity with longer contact times,” the research said.

Reference
VERIFY: Study shows mouthwash may inactivate coronavirus, but not a cure.https://www.wthr.com/article/news/verify/verify-study-mouthwash-inactivate-coronavirus/507-98dcc164-17a8-42b3-bc84-5b55dd100f1d

If Americans would quit complaining concerning face masks

If Americans would quit complaining concerning face masks and use them when they leave their homes, they could conserve well over 100,000 lives — and perhaps more than half a million — through the conclusion of February, based on a study published Friday in Nature Medicine.

The researchers viewed five circumstances for how the pandemic could play out with different levels of mask-wearing and guidelines about staying home and social distancing. All the scenarios presumed that no vaccine was accessible, nor any #medicines capable of curing the disease.

Systematically, the most effective — not to mention the least expensive and easiest — way to minimize deaths was to increase the number of individuals wearing masks.

As of Sept. 21, only 49% of Americans stated they “always” used a mask in public, corresponding to the study. If U.S. citizens do not mask up in increasing numbers, they jeopardize another round of compulsory social distancing measures that could shut businesses and schools around the country, the authors mentioned.

“The potential lifesaving benefit of maximizing mask use in the following fall and winter cannot be exaggerated,” wrote the team from the Institute for Health Metrics and Evaluation at the University of Washington.

The forecasts also suggest that if states continue to ease their social distancing mandates and other constraints regardless of the recent rise in #COVID-19 cases, there could be more than 1 million mortality rates in the U.S. by the end of February.

Reference
New study makes it clear: Mask wearing can save lots of lives. https://www.startribune.com/new-study-makes-it-clear-mask-wearing-can-save-lots-of-lives/572850702/

More than 50 percent of U.S. states are experiencing an “uncontrolled spread” of the coronavirus

More than 50 percent of U.S. states are experiencing an “uncontrolled spread” of the coronavirus, according to data published by the website Covidexitstrategy.org. Thirty states are reporting a lot more than 150 new infections a day per one million people.

The internet site’s contributors consist of public health and crisis experts with experience working during the White House, U.S. Department of Health and Human Services, and regarding the Ebola epidemic in West Africa, including Ryan Panchadsaram, an old U.S. Deputy Chief Technology Officer during the White House.

Using the reopening criteria outlined by the White House, Covidexitstrategy.org tracked each state’s progress when it comes to “its reduction in symptoms and cases, health system readiness, and increased testing.”

Reference
‘Uncontrolled Spread’ of COVID in Majority of U.S. States. https://www.newsweek.com/coronavirus-us-cases-rising-most-states-covid-spread-pandemic-1540319

New research shows that the blood type may determine the chances of infected with COVID-19

New research shows that the #blood type may determine the chances of infected with #COVID-19 and its severity.

Danish #scientists compared the blood of more than 473,000 infected individuals to more than two million when looking at the average man or woman.

They found that people who have blood types A, B, and AB were prone to be infected than those with type O.

In an independent study from Canada, researchers looked over nearly 100 hospitalized patients.

Those with blood types A or AB were more likely to have severe #disease requiring mechanical ventilation and dialysis than people with blood type O or B.
Reference:
Blood type could determine severity of COVID-19, new research finds. https://news4sanantonio.com/news/nation-world/blood-type-could-determine-severity-of-covid-19-new-research-finds